RPRX logo

Royalty Pharma plc (RPRX) Net Income

Annual Net Income:

$1.33B-$369.27M(-21.72%)
December 31, 2024

Summary

  • As of today, RPRX annual net profit is $1.33 billion, with the most recent change of -$369.27 million (-21.72%) on December 31, 2024.
  • During the last 3 years, RPRX annual net income has risen by +$89.61 million (+7.22%).
  • RPRX annual net income is now -45.93% below its all-time high of $2.46 billion, reached on December 31, 2019.

Performance

RPRX Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Quarterly Net Income:

$444.21M+$353.58M(+390.11%)
September 30, 2025

Summary

  • As of today, RPRX quarterly net profit is $444.21 million, with the most recent change of +$353.58 million (+390.11%) on September 30, 2025.
  • Over the past year, RPRX quarterly net income has dropped by -$362.15 million (-44.91%).
  • RPRX quarterly net income is now -69.29% below its all-time high of $1.45 billion, reached on December 31, 2019.

Performance

RPRX Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

TTM Net Income:

$1.30B-$362.15M(-21.76%)
September 30, 2025

Summary

  • As of today, RPRX TTM net profit is $1.30 billion, with the most recent change of -$362.15 million (-21.76%) on September 30, 2025.
  • Over the past year, RPRX TTM net income has dropped by -$412.18 million (-24.04%).
  • RPRX TTM net income is now -53.19% below its all-time high of $2.78 billion, reached on September 30, 2020.

Performance

RPRX TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

RPRX Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-21.7%-44.9%-24.0%
3Y3 Years+7.2%+101.5%+45.6%
5Y5 Years-45.9%-28.8%-53.2%

RPRX Net Income Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-21.7%+478.4%-44.9%+172.8%-26.4%+466.0%
5Y5-Year-45.9%+478.4%-44.9%+172.8%-53.2%+466.0%
All-TimeAll-Time-45.9%+478.4%-69.3%+172.8%-53.2%+466.0%

RPRX Net Income History

DateAnnualQuarterlyTTM
Sep 2025
-
$444.21M(+390.1%)
$1.30B(-21.8%)
Jun 2025
-
$90.64M(-79.1%)
$1.66B(-5.9%)
Mar 2025
-
$433.43M(+29.8%)
$1.77B(+32.9%)
Dec 2024
$1.33B(-21.7%)
$334.00M(-58.6%)
$1.33B(-22.4%)
Sep 2024
-
$806.36M(+314.8%)
$1.71B(+66.4%)
Jun 2024
-
$194.38M(+4649.0%)
$1.03B(-13.2%)
Mar 2024
-
-$4.27M(-100.6%)
$1.19B(-30.2%)
Dec 2023
$1.70B(+639.0%)
$718.00M(+488.2%)
$1.70B(+356.5%)
Sep 2023
-
$122.08M(-65.3%)
$372.50M(-20.9%)
Jun 2023
-
$351.34M(-31.0%)
$470.84M(-23.0%)
Mar 2023
-
$509.09M(+183.5%)
$611.10M(+165.6%)
Dec 2022
$230.06M(-81.5%)
-$610.00M(-376.8%)
$230.09M(-74.3%)
Sep 2022
-
$220.41M(-55.2%)
$894.09M(-0.2%)
Jun 2022
-
$491.60M(+283.8%)
$895.48M(-26.0%)
Mar 2022
-
$128.08M(+137.2%)
$1.21B(-2.5%)
DateAnnualQuarterlyTTM
Dec 2021
$1.24B(-27.1%)
$54.00M(-75.7%)
$1.24B(-20.1%)
Sep 2021
-
$221.80M(-72.5%)
$1.55B(-20.6%)
Jun 2021
-
$806.75M(+407.5%)
$1.96B(+11.7%)
Mar 2021
-
$158.98M(-56.7%)
$1.75B(+2.9%)
Dec 2020
$1.70B(-30.9%)
$367.00M(-41.2%)
$1.70B(-38.8%)
Sep 2020
-
$624.25M(+3.7%)
$2.78B(+7.1%)
Jun 2020
-
$601.98M(+451.8%)
$2.60B(+19.5%)
Mar 2020
-
$109.10M(-92.5%)
$2.17B(-11.7%)
Dec 2019
$2.46B(+62.2%)
$1.45B(+228.7%)
$2.46B(+142.5%)
Sep 2019
-
$440.03M(+146.1%)
$1.01B(+76.5%)
Jun 2019
-
$178.77M(-54.9%)
$574.86M(+45.1%)
Mar 2019
-
$396.09M
$396.09M
Dec 2018
$1.52B(+13.0%)
-
-
Dec 2017
$1.34B(+76.3%)
-
-
Dec 2016
$761.89M(+0.4%)
-
-
Dec 2015
$758.71M
-
-

FAQ

  • What is Royalty Pharma plc annual net profit?
  • What is the all-time high annual net income for Royalty Pharma plc?
  • What is Royalty Pharma plc annual net income year-on-year change?
  • What is Royalty Pharma plc quarterly net profit?
  • What is the all-time high quarterly net income for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly net income year-on-year change?
  • What is Royalty Pharma plc TTM net profit?
  • What is the all-time high TTM net income for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM net income year-on-year change?

What is Royalty Pharma plc annual net profit?

The current annual net income of RPRX is $1.33B

What is the all-time high annual net income for Royalty Pharma plc?

Royalty Pharma plc all-time high annual net profit is $2.46B

What is Royalty Pharma plc annual net income year-on-year change?

Over the past year, RPRX annual net profit has changed by -$369.27M (-21.72%)

What is Royalty Pharma plc quarterly net profit?

The current quarterly net income of RPRX is $444.21M

What is the all-time high quarterly net income for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly net profit is $1.45B

What is Royalty Pharma plc quarterly net income year-on-year change?

Over the past year, RPRX quarterly net profit has changed by -$362.15M (-44.91%)

What is Royalty Pharma plc TTM net profit?

The current TTM net income of RPRX is $1.30B

What is the all-time high TTM net income for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM net profit is $2.78B

What is Royalty Pharma plc TTM net income year-on-year change?

Over the past year, RPRX TTM net profit has changed by -$412.18M (-24.04%)
On this page